122 related articles for article (PubMed ID: 2483491)
1. Determination of glial fibrillary acidic protein, S100, myelin basic protein and neuron specific enolase in cerebrospinal fluid from patients suffering from dementia.
Vermuyten K
Acta Neurol Belg; 1989; 89(3-4):318. PubMed ID: 2483491
[No Abstract] [Full Text] [Related]
2. Serum- and CSF-concentrations of brain specific proteins in hydrocephalus.
Beems T; Simons KS; Van Geel WJ; De Reus HP; Vos PE; Verbeek MM
Acta Neurochir (Wien); 2003 Jan; 145(1):37-43. PubMed ID: 12545260
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid markers in neurological disorders.
Massaro AR; Scivoletto G; Tonali P
Ital J Neurol Sci; 1990 Dec; 11(6):537-47. PubMed ID: 1707039
[TBL] [Abstract][Full Text] [Related]
4. The value of studying the cerebrospinal fluid in slow viral and related diseases.
Lowenthal A; Karcher D
Ann N Y Acad Sci; 1994 Jun; 724():68-74. PubMed ID: 7518208
[No Abstract] [Full Text] [Related]
5. Markers of nerve tissue injury in the cerebrospinal fluid in patients with lumbar disc herniation and sciatica.
Brisby H; Olmarker K; Rosengren L; Cederlund CG; Rydevik B
Spine (Phila Pa 1976); 1999 Apr; 24(8):742-6. PubMed ID: 10222523
[TBL] [Abstract][Full Text] [Related]
6. [Neuron-specific enolase and S-100 protein levels in the cerebrospinal fluid of the patients with neurological diseases].
Mokuno K; Kato K; Kawai K; Matsuoka Y; Sobue I
Rinsho Shinkeigaku; 1983 May; 23(5):397-403. PubMed ID: 6883882
[No Abstract] [Full Text] [Related]
7. [Neuron-specific enolase and S-100 protein levels in the cerebrospinal fluid of patients with encephalitis and meningitis].
Mokuno K; Matsuoka Y; Yanagi T; Sobue I; Kato K
Rinsho Shinkeigaku; 1984 Nov; 24(11):1143-8. PubMed ID: 6394188
[No Abstract] [Full Text] [Related]
8. Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones.
Steiner J; Bielau H; Bernstein HG; Bogerts B; Wunderlich MT
J Neurol Neurosurg Psychiatry; 2006 Nov; 77(11):1284-7. PubMed ID: 17043297
[TBL] [Abstract][Full Text] [Related]
9. Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology.
Noppe M; Crols R; Andries D; Lowenthal A
Clin Chim Acta; 1986 Mar; 155(2):143-50. PubMed ID: 2421949
[TBL] [Abstract][Full Text] [Related]
10. Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases.
Verbeek MM; De Jong D; Kremer HP
Ann Clin Biochem; 2003 Jan; 40(Pt 1):25-40. PubMed ID: 12542908
[TBL] [Abstract][Full Text] [Related]
11. Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients.
Brouns R; De Vil B; Cras P; De Surgeloose D; Mariën P; De Deyn PP
Clin Chem; 2010 Mar; 56(3):451-8. PubMed ID: 19959621
[TBL] [Abstract][Full Text] [Related]
12. Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS.
Avasarala JR
Neurology; 2004 Aug; 63(3):599; author reply 599. PubMed ID: 15304618
[No Abstract] [Full Text] [Related]
13. Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants.
Blennow M; Sävman K; Ilves P; Thoresen M; Rosengren L
Acta Paediatr; 2001 Oct; 90(10):1171-5. PubMed ID: 11697430
[TBL] [Abstract][Full Text] [Related]
14. Difference in pathogenesis between herpes simplex virus type 1 encephalitis and tick-borne encephalitis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction.
Studahl M; Rosengren L; Günther G; Hagberg L
J Neurol; 2000 Aug; 247(8):636-42. PubMed ID: 11041333
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid proteins in neurology.
Lowenthal A; Crols R; De Schutter E; Gheuens J; Karcher D; Noppe M; Tasnier A
Int Rev Neurobiol; 1984; 25():95-138. PubMed ID: 6206016
[No Abstract] [Full Text] [Related]
16. Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients.
Lamers KJ; Vos P; Verbeek MM; Rosmalen F; van Geel WJ; van Engelen BG
Brain Res Bull; 2003 Aug; 61(3):261-4. PubMed ID: 12909296
[TBL] [Abstract][Full Text] [Related]
17. Identification of inflicted traumatic brain injury in well-appearing infants using serum and cerebrospinal markers: a possible screening tool.
Berger RP; Dulani T; Adelson PD; Leventhal JM; Richichi R; Kochanek PM
Pediatrics; 2006 Feb; 117(2):325-32. PubMed ID: 16452350
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of cerebrospinal fluid neuron-specific enolase and S-100b protein in Guillain-Barré syndrome.
Mokuno K; Kiyosawa K; Sugimura K; Yasuda T; Riku S; Murayama T; Yanagi T; Takahashi A; Kato K
Acta Neurol Scand; 1994 Jan; 89(1):27-30. PubMed ID: 8178624
[TBL] [Abstract][Full Text] [Related]
19. [Monoamines, monoamine metabolites, neuron specific enolase and myelin basic protein concentrations in cerebrospinal fluid of resuscitated patients].
Takahashi T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Feb; 17(1):7-16. PubMed ID: 9134533
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid biomarkers in experimental spinal nerve root injury.
Cornefjord M; Nyberg F; Rosengren L; Brisby H
Spine (Phila Pa 1976); 2004 Sep; 29(17):1862-8. PubMed ID: 15534406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
